Mounjaro
The only dual GIP + GLP-1 receptor agonist available in Thailand. Activates two incretin pathways simultaneously for superior appetite suppression and metabolic improvement.
- Up to 22.5% body weight reduction (SURMOUNT-1)
- Dual GIP & GLP-1 receptor activation
- Improves insulin sensitivity and blood sugar
- Once-weekly subcutaneous injection
- Structured 4-step titration: 2.5 โ 5 โ 7.5 โ 10 mg
- Verified authentic from Zuellig Pharma
| Dose | Phase | Price |
|---|---|---|
| 2.5 mg | Starting โ wk 1โ4 | 11,600 |
| 5.0 mg | Step-up โ wk 5โ8 | 13,999 |
| 7.5 mg | Maintenance โ wk 9โ12 | 18,499 |
| 10.0 mg | Higher maint. โ wk 13+ | 20,999 |

